日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775

乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的晚期子宫内膜癌:随机、3期研究309/KEYNOTE-775的5年结果

Makker, Vicky; Colombo, Nicoletta; Casado, Antonio; Santin, Alessandro D; Colomba, Emeline; Miller, David S; Fujiwara, Keiichi; Pignata, Sandro; Yonemori, Kan; Kim, Yong Man; Baron-Hay, Sally; Ray-Coquard, Isabelle; Shapira-Frommer, Ronnie; Kristeleit, Rebecca; Nishio, Shin; Suzuki, Shiro; Guerra Alía, Eva M; Sanli, Ulus A; Selle, Frederic; Shikama, Ayumi; Martínez Rodríguez, Jorge L; Arik, Zafer; Arican, Ali; Sebastianelli, Alexandra; Yu, Zhou; McKenzie, Jodi; Kruger, Stephan; Meng, Robin; Okpara, Chinyere E; Lorusso, Domenica

Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

阿伐替尼±德法替尼治疗复发性低级别浆液性卵巢癌的疗效和安全性:ENGOT-OV60/GOG-3052/RAMP 201研究的主要分析

Banerjee, Susana N; Van Nieuwenhuysen, Els; Aghajanian, Carol; D'Hondt, Véronique; Monk, Bradley J; Clamp, Andrew; Prendergast, Emily; Oaknin, Ana; Ring, Kari; Colombo, Nicoletta; Holloway, Robert W; Rodrigues, Manuel; Chon, Hye Sook; Gourley, Charlie; Santin, Alessandro D; Thaker, Premal H; Gennigens, Christine; Newman, Gregg; Salinas, Erin; Youssoufian, Hagop; Moore, Kathleen N; Lustgarten, Stephanie; O'Malley, David M; Van Gorp, Toon; Grisham, Rachel N

Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results

奥拉帕尼治疗与非铂类化疗治疗铂敏感复发性卵巢癌患者的疗效比较:III期SOLO3研究最终总生存期结果

Scambia, Giovanni; Villalobos Valencia, Ricardo; Colombo, Nicoletta; Cibula, David; Leath, Charles A 3rd; Bidziński, Mariusz; Kim, Jae-Weon; Nam, Joo Hyun; Madry, Radoslaw; Hernández, Carlos; Mora, Paulo A R; Ryu, Sang Young; Ah-See, Mei-Lin; Lowe, Elizabeth S; Lukashchuk, Natalia; Carter, Dave; Penson, Richard T

Systems epigenetic approach towards non-invasive breast cancer detection.

利用系统表观遗传学方法进行非侵入性乳腺癌检测

Herzog Chiara M S, Theeuwes Bente, Jones Allison, Evans Iona, Bjørge Line, Zikan Michal, Cibula David, Harbeck Nadia, Colombo Nicoletta, Pashayan Nora, Widschwendter Martin

Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial

Rucaparib用于铂敏感复发性卵巢癌维持治疗:3期随机、安慰剂对照ARIEL3试验的最终结果

Ledermann, Jonathan A; Oza, Amit M; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Clamp, Andrew R; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstrong, Deborah K; Banerjee, Susana; García-Donas, Jesús; Swisher, Elizabeth M; Lebreton, Coriolan; Konecny, Gottfried E; McNeish, Iain A; Scott, Clare L; Maloney, Lara; Goble, Sandra; Lin, Kevin K; Coleman, Robert L

Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status

在铂敏感复发性卵巢癌患者中,接受奥拉帕尼维持治疗的总生存期与体细胞或生殖系 BRCA 突变状态以及同源重组修复突变状态的关系

Pignata, Sandro; Oza, Amit; Hall, Geoff; Pardo, Beatriz; Madry, Radoslaw; Cibula, David; Klat, Jaroslav; Montes, Ana; Glasspool, Rosalind; Colombo, Nicoletta; Pete, Imre; Herrero Ibáñez, Ana; Romeo, Margarita; Ilieva, Rumyana; Timcheva, Constanta; Di Maio, Massimo; Bashir, Zahid; Taylor, Rosie; Barnicle, Alan; Clamp, Andrew

Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer

利用临床基因组数据库中的真实世界数据,解决高级别浆液性卵巢癌患者的治疗缺口

Ciniselli, Chiara Maura; Conca, Elena; Bartoletti, Michele; Colombo, Nicoletta; Malapelle, Umberto; Lopez, Salvatore; Pignata, Sandro; Raspagliesi, Francesco; Verderio, Paolo; Zamagni, Claudio; Barbiero, Valentina Sara; Castellani, Silvia; Sicari, Emilia; Agnelli, Luca; Perrone, Federica; Pruneri, Giancarlo

Quantitative Proteomics and Phosphoproteomics Analysis of Patient-Derived Ovarian Cancer Stem Cells.

患者来源卵巢癌干细胞的定量蛋白质组学和磷酸化蛋白质组学分析

Franciosa Giulia, Nieddu Valentina, Battistini Chiara, Caffarini Miriam, Lupia Michela, Colombo Nicoletta, Fusco Nicola, Olsen Jesper V, Cavallaro Ugo

Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study

携带生殖系BRCA致病变异的卵巢癌患者接受PARP抑制剂治疗后血液学不良事件:一项回顾性队列研究

Valenza, Carmine; Nicolò, Eleonora; Mongillo, Marta; Trapani, Dario; Katrini, Jalissa; Boldrini, Laura; Boscolo Bielo, Luca; Castellano, Grazia; Guidi, Lorenzo; Pellizzari, Gloria; Villa, Jacopo; Derio, Silvia; Lapresa, Mariateresa; Gigli, Federica; Parma, Gabriella; Omodeo Salè, Emanuela; Derenzini, Enrico; Curigliano, Giuseppe; Colombo, Nicoletta

Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis

帕博利珠单抗联合化疗(加或不加贝伐珠单抗)治疗东亚持续性、复发性或转移性宫颈癌患者:KEYNOTE-826最终分析结果

Kim, Yong-Man; Nishio, Shin; Kim, Se Ik; Hasegawa, Kosei; Dubot, Coraline; Cáceres, M Valeria; Tewari, Krishnansu S; Lorusso, Domenica; Lee, Jeong-Won; Liou, Wen-Shiung; Li, Kan; Tekin, Cumhur; Colombo, Nicoletta; Monk, Bradley J